Global Competent E.coli Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Competent E.coli Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Transformation of bacteria with plasmids is important because bacteria are used as the means for both storing and replicating plasmids. E. coli cells are more likely to incorporate foreign DNA if their cell walls are altered so that DNA can pass through more easily. Such cells are said to be "competent."
Competent E.coli report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Competent E.coli market is projected to reach US$ 151.8 million in 2033, increasing from US$ 115 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2033. Demand from Molecular Cloning and Plasmid Extraction are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Competent E.coli industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Competent E.coli key manufacturers include Thermo Fisher Scientific Inc, Promega, Merck KGaA, New England Biolabs, Agilent Technologies, Takara Bio, Edge BioSystems, TransGen Biotech and Nanjing GenScript Biotechnology, etc. Thermo Fisher Scientific Inc, Promega, Merck KGaA are top 3 players and held % sales share in total in 2022.
Competent E.coli can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % sales share globally in 2022.
Competent E.coli is widely used in various fields, such as Molecular Cloning, Plasmid Extraction and Other,, etc. Molecular Cloning provides greatest supports to the Competent E.coli industry development. In 2022, global % sales of Competent E.coli went into Molecular Cloning filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Competent E.coli market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific Inc
Promega
Merck KGaA
New England Biolabs
Agilent Technologies
Takara Bio
Edge BioSystems
TransGen Biotech
Nanjing GenScript Biotechnology
GCC Biotech
SMOBIO Technology
QIAGEN N.V.
OriGene
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Molecular Cloning
Plasmid Extraction
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Competent E.coli market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Competent E.coli, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Competent E.coli industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Competent E.coli in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Competent E.coli introduction, etc. Competent E.coli Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Competent E.coli market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Competent E.coli report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Competent E.coli market is projected to reach US$ 151.8 million in 2033, increasing from US$ 115 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2033. Demand from Molecular Cloning and Plasmid Extraction are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Competent E.coli industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Competent E.coli key manufacturers include Thermo Fisher Scientific Inc, Promega, Merck KGaA, New England Biolabs, Agilent Technologies, Takara Bio, Edge BioSystems, TransGen Biotech and Nanjing GenScript Biotechnology, etc. Thermo Fisher Scientific Inc, Promega, Merck KGaA are top 3 players and held % sales share in total in 2022.
Competent E.coli can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % sales share globally in 2022.
Competent E.coli is widely used in various fields, such as Molecular Cloning, Plasmid Extraction and Other,, etc. Molecular Cloning provides greatest supports to the Competent E.coli industry development. In 2022, global % sales of Competent E.coli went into Molecular Cloning filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Competent E.coli market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific Inc
Promega
Merck KGaA
New England Biolabs
Agilent Technologies
Takara Bio
Edge BioSystems
TransGen Biotech
Nanjing GenScript Biotechnology
GCC Biotech
SMOBIO Technology
QIAGEN N.V.
OriGene
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Molecular Cloning
Plasmid Extraction
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Competent E.coli market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Competent E.coli, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Competent E.coli industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Competent E.coli in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Competent E.coli introduction, etc. Competent E.coli Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Competent E.coli market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.